World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Cytek Biosciences Inc.

    World Rank (Jan-05-2024)
    8,052
    Market Cap (Jan-05-2024)
    1.112 Billion USD
    World Rank (Jul-30-2023)
    7,760
    Market Cap (Jul-30-2023)
    1.220 Billion USD
    World Rank (Dec-25-2022)
    6,961
    Market Cap (Dec-25-2022)
    1.365 Billion USD
    World Rank (Jan-07-2022)
    6,109
    Market Cap (Jan-07-2022)
    2.09 Billion USD
    Annual Revenue in USD
    164 Million USD
    Annual Operating Income in USD
    -2 Million USD
    Annual Net Income in USD
    3 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Cytek Biosciences, INC is a Cell Analysis to Fuel Scientific Discovery company focused on cancer biology, immunology and genomics. The company annual revenue is 128 million USD  as on 2021. The headquarters is in USA.
    Company Website
    CYTEK BIOSCIENCES, INC.

  2. Guizhou Sanli Pharmaceutical Co. Ltd

    World Rank (Jan-05-2024)
    8,067
    Market Cap (Jan-05-2024)
    1.110 Billion USD
    World Rank (Jul-30-2023)
    8,730
    Market Cap (Jul-30-2023)
    1.003 Billion USD
    World Rank (Dec-25-2022)
    9,179
    Market Cap (Dec-25-2022)
    0.860 Billion USD
    World Rank (Jan-07-2022)
    9,225
    Market Cap (Jan-07-2022)
    1.04 Billion USD
    Headquarters Country
    China
    Company Website
    GUIZHOU SANLI PHARMACEUTICAL CO., LTD.

  3. Zentalis Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    8,087
    Market Cap (Jan-05-2024)
    1.106 Billion USD
    World Rank (Jul-30-2023)
    5,954
    Market Cap (Jul-30-2023)
    1.885 Billion USD
    World Rank (Dec-25-2022)
    8,174
    Market Cap (Dec-25-2022)
    1.043 Billion USD
    World Rank (Jan-07-2022)
    4,662
    Market Cap (Jan-07-2022)
    3.16 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -227 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Zentalis Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is discovery and development of small molecule therapeutics targeting fundamental biological pathways of cancer. The headquarters is in USA.
    Facts About Company
    The company annual revenue is 7.1 million USD and 71 employees as on 2020.
    Company Website
    ZENTALIS PHARMACEUTICALS, INC.

  4. Zhejiang Jolly Pharmaceutical

    World Rank (Jan-05-2024)
    8,117
    Market Cap (Jan-05-2024)
    1.099 Billion USD
    World Rank (Jul-30-2023)
    8,394
    Market Cap (Jul-30-2023)
    1.074 Billion USD
    World Rank (Dec-25-2022)
    8,407
    Market Cap (Dec-25-2022)
    0.990 Billion USD
    World Rank (Jan-07-2022)
    8,935
    Market Cap (Jan-07-2022)
    1.10 Billion USD
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    ZHEJIANG JOLLY PHARMACEUTICAL

  5. Verve Therapeutics Inc.

    World Rank (Jan-05-2024)
    8,130
    Market Cap (Jan-05-2024)
    1.095 Billion USD
    World Rank (Jul-30-2023)
    7,713
    Market Cap (Jul-30-2023)
    1.232 Billion USD
    World Rank (Dec-25-2022)
    7,827
    Market Cap (Dec-25-2022)
    1.122 Billion USD
    World Rank (Jan-07-2022)
    7,318
    Market Cap (Jan-07-2022)
    1.54 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -165 Million USD
    Annual Net Income in USD
    -157 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Verve Therapeutics is the preeminent company developing gene editing medicines to treat patients with cardiovascular disease. The headquarters is in USA.
    Company Website
    VERVE THERAPEUTICS, INC.

  7. Alpine Immune Sciences

    World Rank (Jan-05-2024)
    8,232
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    11,771
    Market Cap (Jul-30-2023)
    0.585 Billion USD
    World Rank (Dec-25-2022)
    15,748
    Market Cap (Dec-25-2022)
    0.299 Billion USD
    World Rank (Jan-07-2022)
    16,596
    Market Cap (Jan-07-2022)
    0.31 Billion USD
    Annual Revenue in USD
    30 Million USD
    Annual Operating Income in USD
    -58 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ALPINE IMMUNE SCIENCES

  8. Innoviva

    World Rank (Jan-05-2024)
    8,240
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    9,507
    Market Cap (Jul-30-2023)
    0.861 Billion USD
    World Rank (Dec-25-2022)
    8,769
    Market Cap (Dec-25-2022)
    0.924 Billion USD
    World Rank (Jan-07-2022)
    8,422
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    331 Million USD
    Annual Operating Income in USD
    206 Million USD
    Annual Net Income in USD
    213 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Innoviva is a Pharmaceutical company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited. The headquarters is in USA.
    Company Website
    INNOVIVA INC

  9. Zhejiang Ausun Pharmaceutical

    World Rank (Jan-05-2024)
    8,281
    Market Cap (Jan-05-2024)
    1.065 Billion USD
    World Rank (Jul-30-2023)
    7,737
    Market Cap (Jul-30-2023)
    1.225 Billion USD
    World Rank (Dec-25-2022)
    6,487
    Market Cap (Dec-25-2022)
    1.525 Billion USD
    World Rank (Jan-07-2022)
    7,500
    Market Cap (Jan-07-2022)
    1.48 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Website
    ZHEJIANG AUSUN PHARMACEUTICAL

  10. 89Bio Inc.

    World Rank (Jan-05-2024)
    8,293
    Market Cap (Jan-05-2024)
    1.062 Billion USD
    World Rank (Jul-30-2023)
    7,991
    Market Cap (Jul-30-2023)
    1.162 Billion USD
    World Rank (Dec-25-2022)
    12,003
    Market Cap (Dec-25-2022)
    0.532 Billion USD
    World Rank (Jan-07-2022)
    17,461
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -102 Million USD
    Annual Net Income in USD
    -102 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    89bio is a Clinical Stage Biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio metabolic diseases. The headquarters is in USA.

    Company Website
    89BIO

Share